PRESIDENT & CEO, HALOZYME THERAPEUTICS
Dr. Helen Torley has led Halozyme since 2014. Dr. Torley brings extensive drug development, commercial and general management experience to her role at the oncology-focused biotech. She has also held senior leadership roles with Onyx, Amgen and Bristol-Myers Squibb. Dr. Torley’s passion for advancing new medicine for patients began when she was a practicing rheumatologist in Scotland
